Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Angiotensin (1-7): Experimental Workflows & Translational...

    2026-01-03

    Angiotensin (1-7): Experimental Workflows & Translational Impact

    Principle Overview: The Multifaceted Role of Angiotensin (1-7)

    Angiotensin (1-7) (sequence: Asp-Arg-Val-Tyr-Ile-His-Pro) is a potent endogenous heptapeptide hormone recognized for its unique counter-regulatory effects within the renin–angiotensin system (RAS). Acting primarily as a Mas receptor agonist, Ang-(1-7) orchestrates a multitude of cellular responses, including modulation of PI3K/AKT signaling, ERK pathway regulation, and downstream effectors such as nitric oxide (NO), FOXO1, and COX-2. These properties underpin its broad utility as an anti-fibrotic and anti-inflammatory agent, as well as its role in metabolic regulation and insulin sensitivity, cerebroprotection in ischemic stroke, and as an anti-cancer agent inhibiting angiogenesis.

    Unlike classical RAS peptides, Ang-(1-7) demonstrates robust activity across cardiovascular, renal, hepatic, pulmonary, and neurological models, making it an invaluable tool for both basic and translational research. As detailed in the recent reference study, the nuanced interactions of angiotensin peptides—including Ang-(1-7)—extend even to viral pathogenesis, highlighting the peptide’s evolving relevance.

    Step-By-Step Experimental Workflows: From Bench to In Vivo

    Peptide Handling and Preparation

    • Storage: APExBIO’s Angiotensin (1-7) (SKU: A1041) arrives as a solid peptide with >99.7% purity, confirmed by HPLC and mass spectrometry. Store desiccated at -20°C to maintain stability.
    • Solubility: Dissolve in water (≥48.5 mg/mL) or DMSO (≥89.9 mg/mL); do not use ethanol due to insolubility.
    • Aliquoting: Prepare small aliquots for short-term use to avoid repeated freeze-thaw cycles, which may degrade peptide integrity.

    In Vitro Workflow: TGF-β-ERK Pathway Inhibition in Renal Cells

    1. Cell Model Selection: Use rat kidney NRK-52E cells for studying fibrogenic transitions.
    2. Peptide Treatment: Add Ang-(1-7) at 100 nM to culture medium. Incubate for desired time (typically 24–48 hours).
    3. Downstream Assays: Assess myofibroblast transition markers (e.g., α-SMA, fibronectin) via immunofluorescence or Western blot.
    4. Pathway Validation: Confirm inhibition of TGF-β-induced ERK phosphorylation. The effect is reversible with the Mas antagonist A779, demonstrating specificity.

    For detailed anti-fibrotic and anti-inflammatory workflows, refer to this comprehensive guide, which complements the above protocol with optimization strategies for translational studies.

    In Vivo Workflow: Experimental Colitis and Beyond

    1. Animal Selection: BALB/c mice are commonly used for colitis models.
    2. Induction of Disease: Administer dextran sulfate sodium (DSS) to induce colitis.
    3. Peptide Administration: Inject Ang-(1-7) intraperitoneally at 0.01–0.06 mg/kg daily during the disease induction period.
    4. Outcome Measurement: Evaluate disease activity index, colon length, and histopathological scores. Quantify phosphorylation of p38, ERK1/2, and Akt as readouts of inflammatory signaling.

    This workflow is further expanded upon in this protocol-focused article, which details metabolic and renal models, illustrating how Ang-(1-7) unlocks targeted investigation of signaling modulation.

    Advanced Applications & Comparative Advantages

    Beyond Classical RAS Research

    • Anti-Fibrotic & Anti-Inflammatory Agent: Ang-(1-7) outperforms classical RAS agents in suppressing fibrosis and inflammation in lung, liver, and kidney tissues by modulating PI3K/AKT and ERK pathways.
    • Metabolic Regulation: Enhances glucose uptake and lipolysis while reducing insulin resistance and dyslipidemia—key for diabetes and metabolic syndrome studies.
    • Cerebroprotection in Ischemic Stroke: Attenuates neuronal injury and supports cognitive recovery, with quantifiable improvements in learning and memory tasks.
    • Oncology Applications: Inhibits cell proliferation and angiogenesis, positioning Ang-(1-7) as a novel anti-cancer agent. Preclinical models show reduced tumor growth and vascularization.
    • Reproductive Health: Promotes ovulation, spermatogenesis, and steroid synthesis, opening avenues for research in fertility and endocrinology.

    Recent findings, such as those from Oliveira et al. (2025), extend the translational relevance of angiotensin peptides by demonstrating their impact on viral pathogenesis. Notably, C-terminal deletions to Ang-(1-7) enhance SARS-CoV-2 spike–AXL binding, suggesting new therapeutic targeting strategies.

    For a mechanistic deep-dive into these pathways, this article offers an extension of the current discussion, focusing on viral pathogenesis and metabolic regulation.

    Comparative Advantages over Traditional Agents

    • Targeted Modulation: Ang-(1-7) provides more specific PI3K/AKT and ERK pathway regulation than angiotensin II, with fewer off-target pro-hypertensive or pro-inflammatory effects.
    • High Purity for Reproducibility: APExBIO’s peptide (>99.7% purity) ensures batch-to-batch consistency, minimizing experimental variability.
    • Flexible Solubility: High solubility in both water and DMSO enables compatibility with diverse in vitro and in vivo protocols.

    Troubleshooting & Optimization Strategies

    • Peptide Stability: Always store aliquots at -20°C and avoid repeated freeze-thaw cycles. For aqueous solutions, use within 24–48 hours to prevent degradation.
    • Solubility Issues: If precipitation occurs, gently warm the solution to room temperature and vortex. Use DMSO for applications requiring higher concentration.
    • Assay Sensitivity: Validate peptide activity with positive controls (e.g., known Mas receptor agonists) and negative controls (e.g., A779 antagonist).
    • Dose Optimization: Start with literature-supported concentrations (e.g., 100 nM for NRK-52E cells; 0.01–0.06 mg/kg for mice) and titrate as needed. Overdosing may induce off-target effects or toxicity.
    • Batch Verification: Confirm peptide identity and purity via HPLC or mass spectrometry if experimental results are inconsistent.

    For additional troubleshooting guidance, this workflow guide provides actionable tips and optimization strategies, particularly relevant for advanced signaling and translational models.

    Future Outlook: Expanding the Translational Horizon

    The versatility of Angiotensin (1-7) positions it at the forefront of next-generation translational research. Its ability to modulate overlapping signaling pathways—PI3K/AKT, ERK, and beyond—enables multifaceted applications from bench research to therapeutic development. Emerging studies, such as those exploring peptide modifications and their impact on viral binding (see Oliveira et al.), are opening new frontiers in infectious disease and immunology.

    APExBIO’s high-purity Ang-(1-7) ensures that researchers can confidently explore these new domains, whether dissecting disease mechanisms, screening for novel therapeutics, or advancing clinical translation. As the understanding of the RAS expands, so too will the experimental and therapeutic horizons of Ang-(1-7)—from combating fibrosis and metabolic disorders to mitigating viral pathogenesis and cancer progression.

    Conclusion

    With its proven efficacy across renal and cardiovascular research, anti-fibrotic and anti-inflammatory models, and emerging relevance in metabolic and infectious disease, Angiotensin (1-7) (Asp-Arg-Val-Tyr-Ile-His-Pro) is a cornerstone tool for modern translational science. Leveraging the high-quality offering from APExBIO, researchers can unlock unparalleled reproducibility, specificity, and experimental insight—transforming both discovery and application in the life sciences.